Evidence map›Paper›PMID 35510174›Full record

ArticleBioactive materials2023

A bioactive compliant vascular graft modulates macrophage polarization and maintains patency with robust vascular remodeling.

Alexander Stahl, Dake Hao, Janos Barrera, Dominic Henn, Sien Lin, Seyedsina Moeinzadeh, Sungwoo Kim, William Maloney, Geoffrey Gurtner, Aijun Wang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Bioactive materials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Research Progress on Biomaterials with Immunomodulatory Effects in Bone Regeneration.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  13. Article
  14. Article
  15. Porous Hydrogels for Immunomodulatory Applications.International journal of molecular sciences · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Alexander StahlDepartment of Orthopaedic Surgery, Stanford University, 240 Pasteur Drive, Stanford, CA, 94304, USA.
Dake HaoDepartment of Surgery, School of Medicine, University of California Davis, Sacramento, CA, 95817, USA.
Janos BarreraDepartment of Surgery, Stanford University, 300 Pasteur Drive, Stanford, CA, 94305, USA.
Dominic HennDepartment of Surgery, Stanford University, 300 Pasteur Drive, Stanford, CA, 94305, USA.
Sien LinDepartment of Orthopaedic Surgery, Stanford University, 240 Pasteur Drive, Stanford, CA, 94304, USA.
Seyedsina MoeinzadehDepartment of Orthopaedic Surgery, Stanford University, 240 Pasteur Drive, Stanford, CA, 94304, USA.
Sungwoo KimDepartment of Orthopaedic Surgery, Stanford University, 240 Pasteur Drive, Stanford, CA, 94304, USA.
William MaloneyDepartment of Orthopaedic Surgery, Stanford University, 240 Pasteur Drive, Stanford, CA, 94304, USA.
Geoffrey GurtnerDepartment of Surgery, Stanford University, 300 Pasteur Drive, Stanford, CA, 94305, USA.
Aijun WangDepartment of Surgery, School of Medicine, University of California Davis, Sacramento, CA, 95817, USA.
Yunzhi Peter YangDepartment of Orthopaedic Surgery, Stanford University, 240 Pasteur Drive, Stanford, CA, 94304, USA.
Stanford University · USShriners Hospitals for Children · US

Funding

Microengineered Osteons for Bone Tissue EngineeringR01AR057837 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI YANG, YUNZHI · 2010 to 2018
$5.1M
Systems Modeling Guided Bone regenerationU01AR069395 · NIAMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI YANG, YUNZHI, ZHOU, XIAOBO · 2016 to 2021
$3.4M
Tissue Engineering Approaches for Improved Treatment of Early Stage Osteonecrosis of the HipR01AR072613 · NIAMS · STANFORD UNIVERSITY · PI GOODMAN, STUART B, YANG, YUNZHI · 2018 to 2022
$2.2M
Vascularization in bone tissue engineering constructsR01AR074458 · NIAMS · STANFORD UNIVERSITY · PI YANG, YUNZHI · 2019 to 2023
$1.7M
NIAMS NIH HHS R01 AR057837NIAMS NIH HHS R01 AR072613NIAMS NIH HHS R01 AR074458NIAMS NIH HHS U01 AR069395
6 · The paper itself

Abstract

Conventional synthetic vascular grafts are associated with significant failure rates due to their mismatched mechanical properties with the native vessel and poor regenerative potential. Though different tissue engineering approaches have been used to improve the biocompatibility of synthetic vascular grafts, it is still crucial to develop a new generation of synthetic grafts that can match the dynamics of native vessel and direct the host response to achieve robust vascular regeneration. The size of pores within implanted biomaterials has shown significant effects on macrophage polarization, which has been further confirmed as necessary for efficient vascular formation and remodeling. Here, we developed biodegradable, autoclavable synthetic vascular grafts from a new polyurethane elastomer and tailored the grafts' interconnected pore sizes to promote macrophage populations with a pro-regenerative phenotype and improve vascular regeneration and patency rate. The synthetic vascular grafts showed similar mechanical properties to native blood vessels, encouraged macrophage populations with varying M2 to M1 phenotypic expression, and maintained patency and vascular regeneration in a one-month rat carotid interposition model and in a four-month rat aortic interposition model. This innovative bioactive synthetic vascular graft holds promise to treat clinical vascular diseases.

Indexed as

Macrophage polarizationPore sizeVascular complianceVascular graftVascular remodeling

Identifiers

PMID35510174
PMCPMC9034314
OpenAlexW4223908058

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.